Universitaetsklinikum Tuebingen AöR

Hematology and Cell Therapy

Clinical research includes acute myeloid leukemia, myelodysplastic neoplasms, chronic lymphocytic leukemia, lymphoma, and acute lymphoblastic leukemia, with activity across relapsed, refractory, and post-transplant settings.

  • Allogeneic stem cell transplantation
  • B-cell malignancies
  • Minimal residual disease
  • Leukemia vaccination

Research also covers fusion-driven sarcomas, fibrolamellar hepatocellular carcinoma, and immunotherapy-based approaches in advanced blood cancers and solid tumors.

Neuro-oncology and Neurology

Trials address glioblastoma, leptomeningeal disease, Parkinson disease, and disorders of brain injury and impaired vigilance, including hypoxic-ischemic encephalopathy and unresponsive wakefulness syndrome.

  • Intrathecal immunotherapy
  • Dopaminergic symptom control
  • Neurorecovery
  • Consciousness impairment

Additional work includes treatment strategies for chronic depression and neurological complications associated with severe illness.

Ophthalmology and Inherited Retinal Disease

Research activity includes acute central retinal artery occlusion, retinopathy of prematurity, achromatopsia, and retinitis pigmentosa, spanning both acquired and genetic causes of vision loss.

  • Retinal ischemia
  • Gene therapy
  • Prematurity-related eye disease
  • Visual function recovery

The portfolio reflects interest in restoring or preserving retinal function in paediatric and adult populations.

Pediatric, Neonatal, and Respiratory Care

Trials focus on extremely preterm infants, prematurity complications, and neonatal outcomes after asphyxia, with attention to respiratory support and neurodevelopment.

  • Mechanical ventilation
  • Therapeutic hypothermia
  • Neurodevelopmental impairment
  • Retinopathy of prematurity

Research also includes prevention and management of neonatal complications in intensive care settings.

Oncology, Metabolic Disease, and Infectious Disease

Studies extend to prostate cancer, rectal cancer, melanoma, and prediabetes, alongside work in malaria, COVID-19, and Staphylococcus aureus colonization.

  • PSMA-targeted therapy
  • Radiochemotherapy
  • Glucose metabolism
  • Vaccine immunogenicity

These trials encompass both cancer-directed treatment and prevention-oriented research in infectious and metabolic conditions.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study of Personalized Peptide Vaccine with PERVI-FUS, PERVI-NEO, and 11902A for Children and Young Adults with Metastatic Fusion-Driven Sarcomas

    Recruiting

    2 1 1
    Germany
  • Study on Oral Propranolol for Preventing Severe Retinopathy in Premature Infants

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany
  • Efficacy of intravenous prasinezumab versus placebo in Parkinson’s disease patients with severe GBA mutation: a 104‑week randomized double‑blind study

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    France Germany Italy Luxembourg Spain Sweden
  • Study of Belimumab with Rituximab and Venetoclax for Patients with Refractory or Relapsed Chronic Lymphocytic Leukemia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany
  • Study on Automatic Oxygen Control for Extremely Preterm Infants Using Oxygen PH.EUR.

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Germany
  • Study on the Effect of Allopurinol and Hypothermia for Newborns with Hypoxic-Ischemic Encephalopathy

    Not recruiting

    3 1 1
    Austria Belgium Estonia Finland Germany Italy +3